Perspective Therapeutics (CATX) Earnings Date & Reports
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more
CATX is expected to report earnings to rise 15.76% to -28 cents per share on August 08
Q2'25
Est.
$-0.29
Q1'25
Beat
by $0.06
Q4'24
Missed
by $0.30
Q3'24
Est.
$-0.21
Q2'24
Missed
by $0.16
The last earnings report on May 13 showed earnings per share of -25 cents, beating the estimate of -31 cents. With 685.03K shares outstanding, the current market capitalization sits at 751.25M.